Skip to main content
Download PDF

Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms

Clinical Proteomics volume 13, Article number: 3 (2016) Cite this article

The Original Article was published on 22 January 2016

Erratum to: Clin Proteom (2016) 13:2 DOI 10.1186/s12014-016-9103-3

It has come to the publisher’s attention that the original version of this article [1] unfortunately contained an unnecessarily complicated version of the data in Table 1. This Erratum replaces Table 1 of the original article with the table below.

Table 1 Range of molecular weights and isoelectric points (99th percentile) of ENOX2 transcript variants for 16 common cancer types compared with mesothelioma [Unpublished data from the ONCOblot Tissue of Origin Database, MorNuCo, Inc]
Full size table

Reference

  1. Morré DJ, Hostetler B, Taggart DJ, Morré DM, Musk AW, Robinson BWS, Creaney J. ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms. Clin Proteom. 2016;13:2.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MorNuCo, Inc, Purdue University Research Park, 1201B Cumberland Avenue, West Lafayette, IN, USA

    D. James Morré, Brandon Hostetler, David J. Taggart & Dorothy M. Morré

  2. National Centre for Asbestos Related Disease, University of Western Australia, Perth, Australia

    A. W. Musk, Bruce W. S. Robinson & Jenette Creaney

  3. School of Medicine and Pharmacology, University of Western Australia, Perth, Australia

    A. W. Musk, Bruce W. S. Robinson & Jenette Creaney

  4. Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Australia

    A. W. Musk & Bruce W. S. Robinson

  5. School of Population Health, University of Western Australia, Perth, Australia

    A. W. Musk

Authors
  1. D. James Morré
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brandon Hostetler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David J. Taggart
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dorothy M. Morré
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. W. Musk
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bruce W. S. Robinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jenette Creaney
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. James Morré.

Additional information

The online version of the original article can be found under doi:10.1186/s12014-016-9103-3.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Morré, D.J., Hostetler, B., Taggart, D.J. et al. Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms. Clin Proteom 13, 3 (2016). https://doi.org/10.1186/s12014-016-9105-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12014-016-9105-1

Clinical Proteomics

ISSN: 1559-0275